Cycad Group
Cycad Group is a venture capital firm focused on investing in technology companies. Their investment strategy involves making early-stage initial investments and participating in follow-on financings to support portfolio companies' growth. They prefer to co-invest with other experienced investors and seek opportunities where technology and market risks have been addressed. Cycad Group acts as a partner to its portfolio companies, providing support and resources beyond capital investment.
Services
Investment and Advisory
Cycad Group provides enthusiastic support and constructive criticism to its portfolio companies. They act as active advisors, assisting management in the development and execution of business and financial strategies. They often seek board observation rights or the right to designate a representative to the board of directors of a portfolio company.
Investment and Advisory
Cycad Group provides enthusiastic support and constructive criticism to its portfolio companies. They act as active advisors, assisting management in the development and execution of business and financial strategies. They often seek board observation rights or the right to designate a representative to the board of directors of a portfolio company.
Portfolio
Advanced Bionics has been acquired by Boston Scientific Corporation.
#Neurostimulation
Agile has exclusively licensed certain of its key technologies to TriQuint.
#Wireless Communications
Alsius has been acquired by a wholly-owned subsidiary of ZOLL Medical Corporation.
#Medical Devices
Renovis acquired Centaur Pharmaceuticals, Inc. in December 2002.
#Pharmaceuticals
Advanced Bionics has been acquired by Boston Scientific Corporation.
#Neurostimulation
Agile has exclusively licensed certain of its key technologies to TriQuint.
#Wireless Communications
Alsius has been acquired by a wholly-owned subsidiary of ZOLL Medical Corporation.
#Medical Devices
Renovis acquired Centaur Pharmaceuticals, Inc. in December 2002.
#Pharmaceuticals